1. Home
  2. RGEN vs VNT Comparison

RGEN vs VNT Comparison

Compare RGEN & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • VNT
  • Stock Information
  • Founded
  • RGEN 1981
  • VNT 2019
  • Country
  • RGEN United States
  • VNT United States
  • Employees
  • RGEN N/A
  • VNT N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • VNT Industrial Machinery/Components
  • Sector
  • RGEN Health Care
  • VNT Industrials
  • Exchange
  • RGEN Nasdaq
  • VNT Nasdaq
  • Market Cap
  • RGEN 6.5B
  • VNT 5.8B
  • IPO Year
  • RGEN N/A
  • VNT N/A
  • Fundamental
  • Price
  • RGEN $152.80
  • VNT $42.54
  • Analyst Decision
  • RGEN Buy
  • VNT Strong Buy
  • Analyst Count
  • RGEN 11
  • VNT 8
  • Target Price
  • RGEN $167.90
  • VNT $47.43
  • AVG Volume (30 Days)
  • RGEN 972.1K
  • VNT 927.3K
  • Earning Date
  • RGEN 10-28-2025
  • VNT 10-30-2025
  • Dividend Yield
  • RGEN N/A
  • VNT 0.24%
  • EPS Growth
  • RGEN N/A
  • VNT 1.28
  • EPS
  • RGEN N/A
  • VNT 2.63
  • Revenue
  • RGEN $673,956,000.00
  • VNT $3,041,400,000.00
  • Revenue This Year
  • RGEN $16.77
  • VNT $3.19
  • Revenue Next Year
  • RGEN $13.79
  • VNT $5.43
  • P/E Ratio
  • RGEN N/A
  • VNT $16.14
  • Revenue Growth
  • RGEN 8.73
  • VNT 1.16
  • 52 Week Low
  • RGEN $102.97
  • VNT $27.22
  • 52 Week High
  • RGEN $182.52
  • VNT $43.88
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 65.63
  • VNT 59.07
  • Support Level
  • RGEN $143.47
  • VNT $37.99
  • Resistance Level
  • RGEN $157.03
  • VNT $40.21
  • Average True Range (ATR)
  • RGEN 6.17
  • VNT 1.01
  • MACD
  • RGEN 0.64
  • VNT 0.12
  • Stochastic Oscillator
  • RGEN 87.20
  • VNT 99.67

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About VNT Vontier Corporation

Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.

Share on Social Networks: